Immunomodulatory antibody therapy of cancer: the closer, the better - Wikidata - awgldk - TriplyDB

Immunomodulatory antibody therapy of cancer: the closer, the better

Immunomodulatory antibody therapy of cancer: the closer, the better

http://www.wikidata.org/entity/Q35142851

about

The Promise of Preventive Cancer Vaccines Classification of current anticancer immunotherapies State of play and clinical prospects of antibody gene transfer.Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.

P2860

Q26783742-CC99F470-2920-4E0F-BCD0-8274493EDE0E Q35149637-9C52AF8D-C7A5-4460-8719-25F0FD9BF8E3 Q38737706-282AC6BE-4478-42C6-BCBD-8D70E986ED1B Q47325431-8C227731-5113-449F-A5D6-2F1F5C27AB6E

P2860

Immunomodulatory antibody therapy of cancer: the closer, the better

http://www.wikidata.org/entity/Q35142851

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Immunomodulatory antibody therapy of cancer: the closer, the better

@ast

Immunomodulatory antibody therapy of cancer: the closer, the better

@en

type

label

Immunomodulatory antibody therapy of cancer: the closer, the better

@ast

Immunomodulatory antibody therapy of cancer: the closer, the better

@en

prefLabel

Immunomodulatory antibody therapy of cancer: the closer, the better

@ast

Immunomodulatory antibody therapy of cancer: the closer, the better

@en

P1433

Q35142851-B049A25F-DF02-4765-990B-CB49EA20AB7B

P1476

Q35142851-4F76A97F-9490-4FCF-A35A-DF3B8FF3C444

P2093

Q35142851-881417BE-404D-4987-A0FC-3A0C19E9B8A6

Q35142851-93E7E301-FCCB-43B1-9F21-5C23515638C1

P2860

Q35142851-00DC560C-7D7C-4C31-A28F-C27EB12F25FB

Q35142851-0A05D884-D016-4C5B-8F28-428F900515EB

Q35142851-4BEB78B7-5A87-4D1F-8807-2E9FE877FF3D

Q35142851-4D57ED97-284B-4023-98C1-353F97B5E5C8

Q35142851-70F31270-864F-4375-B119-B7C1E1ABE77D

Q35142851-8FB2D6AE-3FD0-4BD0-9AE3-53FCC45B84DE

Q35142851-BA9F20D6-0F0E-4464-8544-B2BA0200B58C

Q35142851-C68DB9C7-2958-4696-B90F-70877AC89065

Q35142851-CBC52A74-0A87-4A1A-B628-D6DEA6821D47

Q35142851-E345FF26-1201-47B5-AC0B-F31B0F8D4B9E

P304

Q35142851-A1901D8A-88B6-4AEF-8BA4-7575635B9B00

P31

Q35142851-51AFCCE1-C844-4E5D-81A4-77EA3ECBC48E

P356

Q35142851-CFAC70ED-1C16-41B3-A629-8C512D261AE6

P407

Q35142851-165C832B-86FE-41B8-8E5B-6D07C4A0DB9D

P433

Q35142851-EA3C4413-8DDA-4816-997C-D4883777FD88

P478

Q35142851-9475FED2-1F14-460A-9FAA-6EFAE522813E

P577

Q35142851-3DDEAE4D-3333-42C2-8B88-57E70B1227BD

P698

Q35142851-7C4711DF-AEFE-4DEC-883E-7D7E9389438D

P932

Q35142851-1A4D88AA-4833-4101-B495-7163F60EF2C1

P356

1078-0432.CCR-14-2111

P1433

Clinical Cancer Research

P1476

Immunomodulatory antibody therapy of cancer: the closer, the better

@en

P2093

Haidong Dong

http://www.w3.org/2001/XMLSchema#string

Roxana S Dronca

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor masses support naive T cell infiltration, activation, and differentiation into effectors

Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells.

Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies.

The Treatment of Inoperable Sarcoma by Bacterial Toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus).

Depleting tumor-specific Tregs at a single site eradicates disseminated tumors.

Long-lasting complete regression of established mouse tumors by counteracting Th2 inflammation

Endogenous tumor-reactive CD8(+) T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growth.

Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies.

P304

944-946

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-14-2111

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25351746

http://www.w3.org/2001/XMLSchema#string

P932

4348171

http://www.w3.org/2001/XMLSchema#string